New findings from a National Eye Institute-led study add a twist on how a widely used cell death marker, annexin-V, can be interpreted in the lab and the clinic for tracking retinal cell death in eye diseases such as glaucoma.
With few exceptions, most retina specialists do not have difficulty making the diagnosis of neovascular age-related macular degeneration (nAMD). Although we spend a lot of…
Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release…
Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October 2024.
To investigate the geometrical feature of the whorl-like corneal nerve in dry eye disease (DED) across different severity levels and subtypes, and to preliminarily explore…
How to approach a patient who is dissatisfied with a “perfect” refractive outcome.
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Purpose To evaluate the effects of ocular residual astigmatism (ORA) on refractive outcomes for patients with astigmatism after keratorefractive lenticule extraction (KLEx) and to identify…
Learn about Glaucoma, Glaucoma signs and symptoms, and how to prevent blindness from Gluacoma
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…
Segmentations of retinal layers in spectral-domain optical coherence tomography (SD-OCT) images serve as a crucial tool for identifying and analyzing the progression of various retinal…
